Pennsylvania 2025-2026 Regular Session

Pennsylvania Senate Bill SB190

Introduced

1/29/25

Refer

1/29/25

Caption

Providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.

Latest SB190 Activity

Companion Bills

No companion bills found.

Similar Bills

VA HB2380

HHR, Secretary of; Pharmacy Benefits Manager & Third-Party Administrator Oversight Work Group.

TX HB2536

Relating to transparency related to drug costs.

MA S875

To promote transparency in prescription drug prices

VA HB1724

Prescription Drug Affordability Board; established, drug cost affordability review, report.

AR HB1531

To Prohibit Pharmaceutical Manufacturers From Restricting Or Limiting Prescription Medications To A Limited Distribution Network Of Out-of-state Pharmacies.

IA SF264

A bill for an act relating to prescription drug affordability, including the creation of a prescription drug affordability board.

MA S895

To promote transparency and prevent price gouging of pharmaceutical drug prices

TX HB4990

Relating to the Texas Pharmaceutical Initiative and a governing board and advisory council for the initiative.